KHN gives readers a chance to comment on a recent batch of stories.
Category: Cost and Quality
The Doctor Didn’t Show Up, but the Hospital ER Still Charged $1,012
A St. Louis-area toddler burned his hand on the stove, and his mom took him to the ER on the advice of her pediatrician. He wasn’t seen by a doctor, and the dressing on the wound wasn’t changed. The bill was more than a thousand dollars.
Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments
The top 12 states using antibody therapies produced by Regeneron and Lilly — which research shows don’t work against the omicron variant — include several Southern states with some of the nation’s lowest vaccination rates, but also California, which ranks among the top 20 for fully vaccinated residents.
‘Heart’ of Little Shell: Newest Federally Recognized Tribe to Open First Clinic
The Little Shell Tribe of Chippewa Indians of Montana plans to open the nation’s newest Indian Health Service clinic in Great Falls on Jan. 31 — marking the first time the tribe will have its culture reflected in health care offerings.
HHS Proposal for Marketplace Plans Carries a Hefty Dose of Consumer Caution
The Department of Health and Human Services issued preliminary rules regarding health insurance marketplaces that aim to deter fraudulent sign-ups for coverage. Experts say the agency’s action indicates a problem exists.
5 Things You Should Know About ‘Free’ At-Home Covid Tests
Telling insurance companies to pay for rapid covid-19 tests is just the latest covid-related cost the federal government expects them to bear. But who really ends up paying for it?
Officials Struggle to Regulate Pop-Up Covid Testing Sites — And Warn Patients to Beware
High demand for covid screening and scarce supply have opened the door to bad actors, and officials in some states are sounding the alarm about dubious street testing operators that could put people’s personal data, their health or wallets at risk.
KHN’s ‘What the Health?’: Dealing With Drug Prices
Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
App Attempts to Break Barriers to Bankruptcy for Those in Medical Debt
Medical bills are a leading reason people get stuck in a cycle of debt. Declaring bankruptcy is one lifeline, but attorney and court fees can put it out of reach. The nonprofit Upsolve created an app it calls the “TurboTax of bankruptcy” to help people hit the reset button and rebuild their financial lives.
Clinics Say California’s New Medicaid Drug Program Will Force Them to Cut Services
On Jan. 1, California started buying prescription drugs for its nearly 14 million Medicaid enrollees, a responsibility that had primarily been held by managed-care insurance plans. State officials estimate California will save hundreds of millions of dollars by flexing its purchasing power, but some health clinics expect to lose money.
